DJIA 18,041.54 -190.48 -1.04%
NASDAQ 5,032.75 -56.61 -1.11%
S&P 500 2,104.20 -21.86 -1.03%
market minute promo

Rexahn Pharmaceuticals (NYSEMKT: RNN)

0.71 -0.01 (-1.39%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

RNN $0.71 -1.39%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $0.72
Previous Close $0.72
Daily Range $0.70 - $0.74
52-Week Range $0.65 - $1.04
Market Cap $127.5M
P/E Ratio -18.00
Dividend (Yield) $0.00 (0.0%)
Volume 595,152
Average Daily Volume 656,936
Current FY EPS -$0.12

Sector

Healthcare

Industry

Drug Makers

Rexahn Pharmaceuticals (RNN) Description

Rexahn Pharmaceuticals Inc. is a clinical stage biopharmaceutical company developing and seeking to deliver novel cures for cancer and disorders of the central nervous system (CNS) to patients worldwide. Website: http://www.rexahn.com/

News & Commentary

This Week in Biotech: NW Bio Soars While Geron Goes Geronimo

Two early-stage study results, a rare hospital exemption approval in Germany, and a devastating full clinical hold for one biotech are among this week's top biotech stories.

Rexahn Pharmaceuticals to Present Data on RX-3117 & Supinoxin at the 2015 American Association for C

Rexahn Pharmaceuticals to Present Data on RX-3117 & Supinoxin at the 2015 American Association for Cancer Research Annual Meeting

Rexahn Pharmaceuticals: One Biotech To Buy For A Catalyst-Filled 2015

UPDATE: MLV & Co Initiates Coverage On Rexahn Pharmaceuticals On Oncology Pipeline With Strategic Fl

UPDATE: MLV & Co Initiates Coverage On Rexahn Pharmaceuticals On Oncology Pipeline With Strategic Flexibility

Onxeo: An Upcoming Mid-Sized Pharma With Ambitions

Rexahn's Lead Drug RX-3117 Beats Lilly's Gemzar In One-To-One Face Off

Rexahn Pharmaceuticals (RNN) Jumps: Stock Rises 12.5% - Tale of the Tape

Can The Uptrend Continue for Rexahn Pharmaceuticals (RNN)? - Tale of the Tape

Update: Rexahn Likens Partnership With Demonstrated Potential Of RX-3117

Why Rexahn Pharmaceuticals (RNN) Could Be Positioned for a Surge? - Tale of the Tape

Rexahn Pharmaceuticals (RNN): Strong Industry, Solid Earnings Estimate Revisions - Tale of the Tape

See More RNN News...

RNN's Top Competitors

RNN $0.71 (-1.39%)
Current stock: RNN
AMGN $159.01 (-2.79%)
Current stock: AMGN
GILD $109.77 (-1.74%)
Current stock: GILD
BIIB $392.88 (-1.45%)
Current stock: BIIB